Hashimoto’s thyroiditis does not directly cause lupus, but having Hashimoto’s substantially raises the odds of developing systemic lupus erythematosus (SLE). A large population-based study from Taiwan found the incidence of new lupus was roughly three and a half to five times higher in people with Hashimoto’s than in matched controls. The relationship between these two conditions is best understood not as one causing the other but as a phenomenon researchers call polyautoimmunity, where a shared set of genetic and immune factors predisposes the same person to more than one autoimmune disease.
How Often the Two Conditions Overlap
The overlap between Hashimoto’s and lupus is more common than many patients or even some clinicians expect, though study estimates vary depending on the population examined. One study of lupus patients in the Middle East found Hashimoto’s in about 13% of the lupus group, compared with roughly 6% in healthy controls, putting the odds of having both conditions at about two and a half times higher than normal.1PubMed. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus A separate study in Brazil found that while the rate of autoimmune thyroid disease specifically was similar between lupus patients and controls, hypothyroidism in general was about three times more common in the lupus group, affecting roughly one in five patients.2Endocrine Practice. Autoimmune Thyroid Disease in Patients With Systemic Lupus Erythematosus
A large Danish registry study put the relationship in even starker terms: people with either Hashimoto’s or Graves’ disease had a relative risk greater than tenfold for lupus compared with people who had no autoimmune thyroid condition.3PubMed. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease That study also showed the pattern wasn’t limited to lupus alone; people with autoimmune thyroid disease had elevated risk for a whole list of other autoimmune conditions, from pernicious anemia to celiac disease to vitiligo. The picture that emerges is that Hashimoto’s doesn’t single out lupus as a partner condition so much as it signals a broader immune system primed to attack the body’s own tissues.
The Population Study That Quantified the Risk
The strongest evidence that Hashimoto’s precedes and statistically predicts new lupus comes from a nationwide cohort study in Taiwan that tracked over 15,000 Hashimoto’s patients and more than 31,000 matched controls over time. The researchers found that the incidence rate of new-onset lupus was about 3.6 times higher in the Hashimoto’s group. After adjusting for other factors, the hazard ratio was even stronger, ranging from about 4.3 to 5.1 depending on the sensitivity analysis used.4PubMed Central. Hashimoto’s thyroiditis increases the risk of new-onset systemic lupus erythematosus: a nationwide population-based cohort study
Those numbers are striking, but a few caveats are worth keeping in mind. The study tracked whether lupus appeared after a Hashimoto’s diagnosis, so it established a temporal sequence. Temporal sequence is necessary for causation, but it isn’t sufficient. People who already see a doctor for one autoimmune disease get more bloodwork and more specialist referrals, which makes them more likely to be diagnosed with a second condition that might have gone unnoticed in someone who wasn’t being monitored. Researchers call this surveillance bias, and it likely inflates the numbers somewhat. Still, the effect sizes were large enough that surveillance bias alone is unlikely to explain the entire association.
Shared Genetics Behind the Overlap
The most likely reason Hashimoto’s and lupus cluster in the same patients is that they share genetic risk factors. A genetic study using data from large genome-wide association datasets found at least two regions on chromosomes 1 and 2 where the same genetic variants appeared to influence both lupus and primary hypothyroidism, suggesting a common biological mechanism linking the two.5The Journal of Clinical Endocrinology & Metabolism. Association Between Systemic Lupus Erythematosus and Primary Hypothyroidism: Evidence from Complementary Genetic Methods In other words, you can inherit a set of immune-related gene variants that make your body more prone to autoimmunity in general, and which specific autoimmune diseases develop depends on additional factors.
This genetic overlap helps explain why autoimmune diseases so often travel in packs. Families with one autoimmune condition frequently have members with a different autoimmune condition. If your mother has Hashimoto’s and your sister has lupus, the family isn’t just unlucky; there’s a shared genetic architecture at work. The specific genes implicated tend to involve how your immune system distinguishes self from non-self, including how certain immune cells are activated and regulated.
The Role of Type I Interferon
One of the strongest shared immune pathways between these conditions involves type I interferon, a family of signaling molecules your immune system uses to fight viruses. In lupus, type I interferon is considered a primary driver of disease. Patients with gene variants that ramp up interferon signaling tend to get more severe lupus, with higher rates of kidney involvement and other organ damage.6PubMed Central. Type I interferon in the pathogenesis of systemic lupus erythematosus What makes this relevant to Hashimoto’s is that type I interferon also plays a role in thyroid autoimmunity. Interferon-alpha therapy, sometimes used to treat hepatitis C, is well known to trigger both Hashimoto’s and lupus-like syndromes in susceptible people.
The interferon connection also explains why both conditions are so much more common in women. Estrogen amplifies type I interferon responses, and certain immune genes on the X chromosome escape the usual silencing process, giving people with two X chromosomes a higher baseline of interferon-related gene activity. This is part of why autoimmune diseases in general disproportionately affect women, but the interferon link makes the female predominance especially sharp in both Hashimoto’s and lupus.
Environmental Triggers Both Conditions Share
Genetics loads the gun, as the saying goes, but something in the environment pulls the trigger. One of the most studied environmental suspects is the Epstein-Barr virus, the common virus that causes mononucleosis. Virtually all lupus patients show evidence of past EBV infection, and the virus has been implicated as a contributory factor in autoimmune thyroid disorders as well.7Central European Journal of Immunology. A possible link between the Epstein-Barr virus infection and autoimmune thyroid disorders EBV doesn’t single-handedly cause either disease, but it appears to be one of several environmental nudges that can tip a genetically susceptible person over the edge into autoimmunity.
Other environmental factors that have been linked to both conditions include vitamin D deficiency, smoking, and chronic stress, though the evidence for each varies in strength. The gut microbiome has also drawn increasing attention. A study of Hashimoto’s patients found significantly higher blood levels of zonulin, a protein that regulates the tight junctions between intestinal cells, suggesting increased intestinal permeability in people with the condition.8PubMed Central. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis A “leakier” gut allows more bacterial products to cross into the bloodstream, which may chronically stimulate the immune system in ways that contribute to autoimmune flares in both thyroid and non-thyroid conditions.
When Lupus and Hashimoto’s Coexist, Does It Change the Prognosis?
Having both conditions at once isn’t just an academic curiosity; it has real clinical consequences. Evidence suggests that untreated hypothyroidism in lupus patients can delay remission. One study tracking over 360 lupus patients with subclinical hypothyroidism found that a delay in treating the thyroid problem corresponded with delayed remission of lupus itself.9PubMed Central. Thyroid Disease in Lupus: An Updated Review That finding carries a practical message: if you have lupus and your thyroid levels are drifting even slightly out of range, treating it early may improve your lupus outcomes, not just your thyroid symptoms.
The cardiovascular picture is also concerning. Lupus on its own already raises the risk of heart disease. Adding hypothyroidism to the mix compounds the problem. One study found that lupus patients with hypothyroidism had higher diastolic blood pressure and substantially higher triglyceride levels than lupus patients with normal thyroid function.10Frontiers in Endocrinology. Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism Cardiac insufficiency was independently associated with hypothyroidism in the lupus group. A separate study examining both lupus and rheumatoid arthritis patients confirmed that those with thyroid dysfunction had increased cardiovascular risk.11The Egyptian Rheumatologist. Thyroid dysfunction in systemic lupus erythematosus and rheumatoid arthritis: Its impact as a cardiovascular risk factor The takeaway is that thyroid function in lupus patients deserves monitoring not just for comfort and energy levels but because it feeds into the broader cardiovascular risk profile that lupus already elevates.
Drug-Induced Lupus From Thyroid Medications
There’s a small but important wrinkle that can confuse the diagnostic picture: certain medications used to treat thyroid conditions can themselves trigger a lupus-like syndrome. Methimazole, a drug commonly prescribed for hyperthyroidism in Graves’ disease, has been reported to cause drug-induced lupus.12PubMed Central. Anti-thyroid drug-induced lupus: a case report and review of the literature Propylthiouracil, another anti-thyroid drug, is even more frequently implicated. Drug-induced lupus typically resolves after the offending medication is stopped, which distinguishes it from true SLE.
This matters because a person being treated for an overactive thyroid who then develops joint pain, skin rashes, or positive ANA blood tests might appear to be developing lupus when the real culprit is the medication. If you have Graves’ disease and new lupus-like symptoms appear after starting an anti-thyroid drug, your doctor should consider drug-induced lupus before assuming you’ve developed a second autoimmune disease. The distinction changes the treatment plan entirely: stopping the drug versus starting lifelong lupus management.
Children and Adolescents With Both Conditions
Polyautoimmunity involving the thyroid isn’t limited to adults. A study of 73 children with childhood-onset lupus found that about 12% had clinical hypothyroidism and roughly 16% met criteria for Hashimoto’s, with rates considerably higher than in healthy controls.13PubMed Central. Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis About the same percentage had a family history of Hashimoto’s, reinforcing the genetic connection. Thyroid dysfunction in children with lupus can be tricky to spot because the symptoms, including fatigue, difficulty concentrating, and weight gain, overlap heavily with lupus symptoms and with the side effects of medications like corticosteroids. Pediatric rheumatologists increasingly recommend routine thyroid screening for children diagnosed with lupus, though no universal guideline mandates it yet.
Pregnancy When Both Conditions Are Present
Pregnancy adds another layer of complexity for women with both lupus and thyroid disease. A study of pregnant women with lupus found that those who also had thyroid disease had a preterm delivery rate of 67%, compared with 18% in lupus patients without thyroid problems.14PubMed. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery That’s a dramatic difference. The study also highlighted that many of the thyroid conditions in these women were previously undiagnosed, picked up only because of pregnancy-related screening.
Lupus pregnancies already carry elevated risks, including preeclampsia, growth restriction, and flares during or after pregnancy. Adding uncontrolled hypothyroidism to that mix amplifies the danger. Thyroid hormone is critical for fetal brain development, and inadequate levels in the first trimester, before the fetus can make its own thyroid hormone, are associated with developmental problems. For women with lupus who are planning a pregnancy, thyroid function testing before conception and monitoring throughout pregnancy isn’t optional; it’s a key part of reducing risk.
Hydroxychloroquine as a Bridge Between the Two Conditions
Hydroxychloroquine, one of the cornerstone drugs in lupus management, has drawn interest as a possible treatment for Hashimoto’s as well. A clinical trial registered on ClinicalTrials.gov was designed to evaluate whether hydroxychloroquine could reduce the thyroid-attacking antibodies (anti-TPO antibodies) that drive Hashimoto’s tissue destruction.15ClinicalTrials.gov. The Effect of Hydroxychloroquine Treatment in Hashimoto’s Thyroiditis The logic is straightforward: hydroxychloroquine dampens the overactive immune signaling that drives autoimmunity, so it might calm the thyroid-specific immune attack as well.
For patients who already take hydroxychloroquine for lupus, this is an intriguing possibility. If the drug they’re already on could also slow the progression of Hashimoto’s, it would represent an efficient two-for-one therapeutic approach. However, the evidence for this remains early-stage, and hydroxychloroquine is not currently a standard treatment for Hashimoto’s. Most Hashimoto’s patients are still managed with thyroid hormone replacement once their own gland can no longer keep up, rather than with immunomodulatory drugs aimed at the underlying autoimmune process.
What Screening Looks Like in Practice
If you have Hashimoto’s and worry about developing lupus, or if you have lupus and wonder about your thyroid, knowing what to watch for can help you advocate for appropriate testing. For Hashimoto’s patients, the lupus red flags include new joint pain that’s worse in the morning, a butterfly-shaped rash across the cheeks and nose, mouth sores, unusual sensitivity to sunlight, and unexplained fevers. A simple ANA blood test is usually the first screening step, though a positive ANA alone doesn’t confirm lupus since many conditions and even healthy people can produce a mildly positive result.
For lupus patients, thyroid symptoms to watch for include fatigue that seems out of proportion to disease activity, constipation, dry skin, unexplained weight gain, and feeling cold when others are comfortable. A standard thyroid panel, consisting of TSH and free T4, is inexpensive and can reveal problems early. Given the overlap documented in the studies above, many rheumatologists now check thyroid function at least annually in lupus patients, even when there are no obvious thyroid symptoms.
The broader message from the research is that autoimmune diseases rarely exist in isolation. If you’ve been diagnosed with one, periodic screening for others, especially those sharing genetic and immune pathways, is a practical and low-cost way to catch problems early. In the case of Hashimoto’s and lupus, early thyroid treatment in lupus patients may improve lupus outcomes, and early lupus detection in Hashimoto’s patients can prevent organ damage that occurs when the disease goes unrecognized for years.
Why Researchers Think in Terms of Polyautoimmunity, Not Causation
The framing of the original question, whether Hashimoto’s “causes” lupus, reflects a natural way of thinking about disease. You had one thing first, then the other appeared, so the first must have caused the second. But the current scientific consensus leans away from a direct causal link and toward the concept of polyautoimmunity, where the same underlying immune dysregulation gives rise to multiple autoimmune diseases, sometimes sequentially, sometimes simultaneously.16Rheumatology & Autoimmunity. Intersection of systemic lupus erythematosus and autoimmune thyroid disease: Shared pathophysiology, epidemiology, diagnosis, and management
Think of it this way: Hashimoto’s appearing first may simply mean that the thyroid happens to be the first organ the immune system targets in that particular person, rather than that the thyroid attack sets off a chain reaction leading to lupus. The shared genetics, the shared interferon pathways, the shared environmental triggers all point to a common upstream cause rather than a sequential domino effect. That said, researchers acknowledge that further work is needed to rule out the possibility that the chronic inflammation generated by one autoimmune disease might genuinely lower the threshold for a second one to develop. The honest answer is that the science hasn’t fully settled this, but the weight of the evidence favors shared susceptibility over direct causation.
Conditions Commonly Mistaken for Lupus in Thyroid Patients
Because Hashimoto’s patients are already primed to worry about additional autoimmune diseases, it’s worth knowing that several conditions can mimic lupus symptoms without actually being lupus. Fibromyalgia, which is more common in people with thyroid disease, produces widespread pain and fatigue that can look like lupus joint involvement. Vitamin D deficiency, common in both Hashimoto’s and lupus patients, causes bone and muscle pain. Even poorly controlled hypothyroidism itself can cause joint stiffness, puffiness in the hands and face, and fatigue severe enough to raise lupus suspicions.
A positive ANA test, which some Hashimoto’s patients get during the diagnostic workup, can also create unwarranted alarm. ANA positivity is found in a meaningful percentage of people with autoimmune thyroid disease who never develop lupus. A borderline or low-titer ANA result in someone with Hashimoto’s does not mean lupus is imminent. The more specific antibodies, like anti-double-stranded DNA and anti-Smith, are much more reliable indicators of lupus, and their absence in the setting of a positive ANA should be reassuring. If your doctor orders additional testing after a positive ANA, that’s appropriate diligence, not a sign that lupus is inevitable.